Background: Behcet’s disease (BD) as a chronic inflammatory condition that affects the eyes, skin, central nervous system, gastrointestinal tract and vessels. According to the literature, the exact value of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in predicting active manifestations of BD remains controversial. In this study, we aim to assess and compare values of ESR and CRP between BD patients with active/inactive BD and active/inactive manifestations of the disease. Moreover, we try to determine the predictive value of ESR and CRP for disease activity. Methods: Participants (n = 514) were drug-naïve BD patients; Based on last two visits, ESR and CRP values, disease activity, and active manifestations were recorded. The Man-Whitney U test measured the associations, and the binomial logistic regression evaluated the predictive value of ESR and CRP for active disease and each active manifestation. The sensitivity and specificity and the area under the curve (AUC) for each model were determined using receiver operating characteristic curves (ROC). Multiple regressions were run to predict BD activity score from ESR and CRP. Result: Patients with active oral, genital, joint and dermal manifestations had higher ESR and CRP values (Mann–Whitney U test, p < 0.05 for all). Binomial logistic regressions showed that ESR had valuable predictive value for active BD (OR = 1.09 [1.04–1.13], AUC = 0.79 [0.74–0.83], p < 0.001) and active vascular manifestations (1.03 [1.01–1.05], AUC = 0.85 [0.79–0.92], p < 0.001). CRP had good predictive value for active vascular manifestations (OR 1.98 [1.45–2.72], AUC = 0.86 [0.8–0.91], p < 0.001). The optimal value of ESR ≥ 10.5 and ESR ≥ 42.5 could predict active BD and active vascular manifestations with sensitivity, specificity = 71%, 75% and = 81%, 83% respectively. Conclusions: ESR and CRP are both associated with active BD and most manifestations of the diseases. They can be used for the prediction of active BD and active vascular manifestations in BD patients. Further studies can help to confirm the findings of the current research.
6 September 2024 in Archives of Dermatological Research
Background: Substance use is associated with psychiatric disorders, contributing to negative outcomes and exacerbating existing conditions. Objectives: This study aimed to investigate the prevalence and patterns of illicit drug use, focusing on cannabis and methamphetamine, in a psychiatric inpatient setting in Iran. Methods: Three hundred adult psychiatric inpatients were included in the study, and data on demographics, substance use patterns, and clinical characteristics were collected. The World Health Organization’s alcohol, smoking, and substance involvement screening test (WHO-ASSIST) was used to screen for substance-related patterns and risks among patients who used methamphetamine or cannabis in the past three months. Results: Among the participants (median age: 35.0 years, 65.3% male), recent substance use was reported by 38.0%, with methamphetamine and cannabis reported by 15.0% and 11.7%, respectively. These were less prevalent compared to alcohol and opioid substances, which were reported by 19.3% and 19%, respectively. Recent cannabis or methamphetamine use was associated with aggression and polysubstance use disorders. Conclusions: The findings revealed that recent cannabis and methamphetamine use were associated with aggression and polysubstance use disorders among psychiatric inpatients. Opioids were the most prevalent illicit drugs consumed.
16 April 2024 in INNOSC Theranostics and Pharmacological Sciences
AccScience Publishing is a publishing company based in Singapore. We have in our portfolio a range of high-quality, open-access, peer-reviewed journals and books from a broad spectrum of science, technology, biomedicine, engineering, education, social sciences and many more.